Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.54% | 13.52% | 9.96% | 8.55% | 7.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.54% | 13.52% | 9.96% | 8.55% | 7.10% |
| Cost of Revenue | 13.88% | 13.02% | 9.77% | 6.67% | 4.96% |
| Gross Profit | 12.47% | 15.15% | 10.56% | 14.96% | 14.50% |
| SG&A Expenses | 15.89% | 14.72% | -3.96% | 19.49% | 16.62% |
| Depreciation & Amortization | 31.41% | 29.21% | 28.47% | 9.36% | -2.48% |
| Other Operating Expenses | -106.90% | -166.67% | -20.97% | -2.94% | 42.00% |
| Total Operating Expenses | 14.52% | 13.44% | 9.89% | 7.45% | 5.42% |
| Operating Income | 8.28% | 14.01% | 10.34% | 14.95% | 17.14% |
| Income Before Tax | -28.03% | 8.96% | 8.74% | 53.49% | 149.39% |
| Income Tax Expenses | 2,184.21% | 44,966.67% | 450.00% | 121.69% | -72.06% |
| Earnings from Continuing Operations | -107.64% | -90.76% | -5.45% | 47.04% | 248.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.89% | -22.69% | -13.82% | -14.56% | -15.10% |
| Net Income | -32,333.33% | -1,312.61% | -76.68% | 37.87% | 100.65% |
| EBIT | 8.28% | 14.01% | 10.34% | 14.95% | 17.14% |
| EBITDA | 13.20% | 17.38% | 14.39% | 13.66% | 12.34% |
| EPS Basic | -31,357.14% | -1,293.51% | -51.43% | 52.05% | 100.53% |
| Normalized Basic EPS | -316.33% | 94.94% | 103.23% | 111.58% | 106.39% |
| EPS Diluted | -76,790.00% | -1,261.02% | -49.95% | 51.86% | 100.22% |
| Normalized Diluted EPS | -312.00% | 83.33% | 103.25% | 111.61% | 106.52% |
| Average Basic Shares Outstanding | 0.38% | 0.41% | 5.33% | 14.02% | 24.28% |
| Average Diluted Shares Outstanding | 0.05% | 0.08% | 4.96% | 13.59% | 24.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |